Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Punctate Palmoplantar Keratoderma Type 1”

2 trials

Showing 2 of 2 results

Early research (Phase 1)Study completedNCT05956314
What this trial is testing

Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC

Who this might be right for
Punctate Palmoplantar Keratoderma Type 1Pachyonychia Congenita
Kamari Pharma Ltd 18
Early research (Phase 1)Study completedNCT05435638
What this trial is testing

Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases

Who this might be right for
Punctate Palmoplantar Keratoderma Type 1Pachyonychia Congenita
Kamari Pharma Ltd 14

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation